Skip to content

Wanmei Aloe Poria Capsule and Compound Probiotics Obesity Intervention Study

Wanmei Aloe Poria Capsule and Compound Probiotics Obesity Intervention Study - APCP-CP-OCIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126989
Enrollment
Unknown
Registered
2026-06-22
Start date
2025-11-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Placebo Group:Subjects took placebos which had the same appearance and specifications as Perfect Aloe and Poria Capsules but contained no active ingredients. The dosage and frequency were 4 capsules e
Aloe and Poria Capsule Group:Subjects took Perfect Aloe and Poria Capsules orally twice a day, 4 capsules each time for 60 consecutive days. No extra exercise or other test products were added, and da
Aloe and Poria Capsule + Exercise Group:Subjects took Aloe and Poria Capsules at the same dosage (twice a day, 4 capsules each time) for 60 days. Meanwhile, they received regular moderate-intensity ae
Aloe and Poria Capsule + Probiotics Group: Subjects took Aloe and Poria Capsules at the standard dosage (twice a day, 4 capsules each time) for 60 days. In addition, they consumed compound probiotic s

Sponsors

Zhongshan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, inclusive. 2. Body Mass Index (BMI) between 24-28 kg/m² or greater than 28 kg/m². 3. Voluntary participation and provision of signed informed consent. 4. Ability and willingness to comply with the entire study procedure..

Exclusion criteria

Exclusion criteria: 1. Suffering from severe diseases of vital organs including the heart, liver, kidney and other important organs. 2. Diagnosed with endocrine disorders, malignant tumors or other diseases that affect body weight. 3. Subjects taking medicines, health supplements or other products that may interfere with body weight and test indicators, which would interfere with outcome evaluation. 4. With a history of mental illness and unable to cooperate with the study procedures. 5. Having participated in other similar clinical trials within the past 3 months. 6. Failure to consume the test sample as required, or incomplete data that hinders efficacy or safety assessment. 7. Use of antibiotics within the previous one month. 8. Women of childbearing age who are preparing for pregnancy or already pregnant shall be excluded.

Design outcomes

Primary

MeasureTime frame
weight;Body Fat Percentage;

Secondary

MeasureTime frame
Waist Circumference;Hip Circumference;Dampness Syndrome Score (TCM) TCM Dampness Syndrome Score;

Countries

China

Contacts

Public ContactWang Jian

Zhongshan Hospital of Traditional Chinese Medicine

zswj@gzucm.edu.cn+86 133 5281 9826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026